| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human,Rat |
| Host species | Goat |
| Applications | ELISA,WB-Ti,IHC-P |
| Brand: | Abnova |
| Reference: | PAB7158 |
| Product name: | FOXP2 polyclonal antibody |
| Product description: | Goat polyclonal antibody raised against synthetic peptide of FOXP2. |
| Gene id: | 93986 |
| Gene name: | FOXP2 |
| Gene alias: | CAGH44|DKFZp686H1726|SPCH1|TNRC10 |
| Gene description: | forkhead box P2 |
| Immunogen: | A synthetic peptide corresponding to internal region of human FOXP2. |
| Immunogen sequence/protein sequence: | C-DEVEYQKRRSQKIT |
| Protein accession: | NP_055306.1;NP_683696.2;NP_683697.2;NP_683698.2;NP_001166237.1 |
| Form: | Liquid |
| Concentration: | 0.5 mg/mL |
| Recommend dilutions: | ELISA (1:64000) Western Blot (0.3-1 ug/mL) Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (2-4 ug/mL) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In Tris saline, pH 7.3 (0.5% BSA, 0.02% sodium azide) |
| Storage instruction: | Store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Goat |
| Antigen species / target species: | Human |
| Specificity: | This antibody is expected to recognize isoform I (NP_055306.1), isoform II (NP_683696.1) and isoform III (NP_683697.1 and NP_683698.1). |
| Reactivity: | Human,Rat |
| Application image: | ![]() |
| Application image note: | FOXP2 polyclonal antibody (Cat # PAB7158) (0.3 ug/mL) staining of human brain (cerebellum) lysate (35 ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence. |
| Applications: | ELISA,WB-Ti,IHC-P |
| Shipping condition: | Dry Ice |
| Publications: | A forkhead-domain gene is mutated in a severe speech and language disorder.Lai CS, Fisher SE, Hurst JA, Vargha-Khadem F, Monaco AP. Nature. 2001 Oct 4;413(6855):519-23. |